Physician profile
Phong Nguyen
NPI 1831389063
$12,362.24
in general payments reported to CMS, 2019-2025
13 companies · $4,462 in 2025
The $4,462 reported for 2025 was more than what 98% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,694 · 2020: $806 · 2021: $806 · 2022: $310 · 2023: $1,407 · 2024: $2,878 · 2025: $4,462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,418 · Travel and Lodging: $3,328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,417.58 |
| Travel and Lodging | $3,328.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $8,953.71 | 2019-2025 | Proclaim, Eterna, Octrode |
| Medtronic, INC. | $1,423.40 | 2024-2025 | Synchromedii, Intellis Adaptivestim |
| Surgentec | $834.55 | 2025 | Tilink, Ion |
| Curonix LLC | $310.57 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Spinal Simplicity, LLC | $221.03 | 2024-2025 | Ha Minuteman G3-R |
| Nevro Corp. | $191.35 | 2019-2024 | Senza |
| Boston Scientific Corporation | $149.10 | 2019-2025 | Wavewriter Alpha Prime 16, Patient Trial Kit, Clinical Trial Product |
| Globus Medical, INC. | $146.78 | 2025 | Senza |
| Foundation Fusion Solutions, LLC | $41.05 | 2024 | |
| Si-Bone, INC. | $38.22 | 2019 | |
| Nalu Medical, INC. | $26.20 | 2024 | Nalu Neurostimulation System |
| Bioventus LLC | $14.96 | 2023 | Stimrouter Implantable Kit |
| Avanos Medical | $11.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phong Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.